4 unknown, 1 completed, 1 suspended, 1 terminated. 3 Phase 4, 2 Phase 2, 1 Early Phase 1, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Completed 1 |
| Phase 2 | 2 | Suspended 1, Unknown 1 |
| Early Phase 1 | 1 | Terminated 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Cefoperazone: new trials by email Literature Review of Cefoperazone trials Research Report on Cefoperazone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate Bioequivalence of Burotam (1/1 g/Vial) cefoperazone sodium and sulbactam sodium - Infectious Diseases | Phase 4 | Unknown | Yung Shin Pharm. Ind. Co., Ltd. | 14 | 2022-08-25 | 2023-02-01 |
| Antibiotic Prophylaxis in Rectal Cancer Surgery: Oral With Intravenous Versus Intravenous Antibiotics. Oral antibiotic, Intravenous antibiotic, Mechanical Bowel Preparation - Rectal Cancer | Not applicable | Unknown | State Scientific Centre of Coloproctology, Russian Federation | 280 | 2017-11-06 | 2019-03-05 |
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
| The Effect of Nebulization of Alkaline Solution on Treating XDRAB Pneumonia With C/S Plus Minocycline C/S plus minocycline., nebulization with pH 7.4 solution, nebulization with pH 7.8 solution - Pneumonia | Phase 1 / Phase 2 | Unknown | Xijing Hospital | 90 | 2014-03-01 | 2014-02-11 |
| Multi-center Clinical Study of Early Antibios of Severe Acute Pancreatitis cefoperazone + metronidazole, oral care by chlorhexidine gluconate, enteral nutrition - Pancreatitis,Acute Necrotizing | Phase 4 | Unknown | Erzhen Chen | 60 | 2012-07-01 | 2013-11-25 |
| Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection High dose, Low dose, Cefoperazone and Sulbactam Sodium (CFP/SUB) - Respiratory Tract Infections, Urinary Tract Infections | Phase 2 | Suspended | Xiangbei Welman Pharmaceutical Co., Ltd | 288 | 2011-11-01 | 2019-07-05 |
| A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections Magnex (Sulbactam Sodium/Cefoperazone Sodium 1:1) Pfizer Ltd., Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited, Metrogyl (Metronidazole Injection IP) J.B.Chemicals & Pharmaceuticals Ltd. - Infection | Phase 4 | Completed | Pfizer | 307 | 2004-07-01 | 2008-12-02 |
Communicable Diseases (1) · Infections (1) · Osteomyelitis (1) · Pancreatitis, Acute Necrotizing (1) · Pneumonia (1) · Rectal Neoplasms (1) · Respiratory Tract Infections (1) · Surgical Wound Infection (1) · Urinary Tract Infections (1)
Erzhen Chen (1) · Julio Ramirez (1) · Pfizer (1) · State Scientific Centre of Coloproctology, Russian Federation (1) · Xiangbei Welman Pharmaceutical Co., Ltd (1) · Xijing Hospital (1) · Yung Shin Pharm. Ind. Co., Ltd. (1)
China (3) · India (1) · Russia (1) · Taiwan (1) · United States (1)
David Seligson, MD (1) · En-Qiang Mao, M.D. & Ph.D. (1) · Er-Zhen Chen, M.D. & Ph.D. (1) · Julio Ramirez, MD (1) · Zhi-Tao Yang, M.D. & Ph.D. (1)
PMID 15276398, PMID 15840453, PMID 18570578, PMID 19588358, PMID 22530208, PMID 4902833, PMID 8948280